Trial intelligence / Profile preview

MMV390048 PK in healthy volunteers

NCT02554799Phase 1Completed

Sponsor
Medicines for Malaria Venture
Start
Sep 2015
Primary completion
Oct 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 1, open-label trial of MMV390048 in malaria, sponsored by Medicines for Malaria Venture. Started Sep 2015; status: completed.

02

Drugs

MMV390048
03

Conditions

malaria

Beyond the preview

Go deeper on NCT02554799.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02554799.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call